PDT Partners’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
PDT Partners's ATRC Position: Q1 2026 in Review
PDT Partners sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 21,201 shares — an estimated $839K sold.
PDT Partners first reported a position in ATRC in Q2 2013 and held it in 22 quarters. The position peaked at $1.47M in Q3 2017. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.
- PDT Partners reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
- PDT Partners sold 21,201 AtriCure shares in Q1 2026, an estimated $839K.
- PDT Partners first reported a position in AtriCure in Q2 2013 and held it in 22 quarters.
- PDT Partners's AtriCure position peaked at $1.47M in Q3 2017.
- 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.
Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.